Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?

Main Article Content

Roberto F.E. Pedretti *
(*) Corresponding Author:
Roberto F.E. Pedretti | roberto.pedretti@icsmaugeri.it

Abstract

Some observational studies raised questions about the need for β-blockers in all patients after a first heart attack. Surprisingly, in some clinical settings, a limited mortality reduction was found in those who received β-blockade.Some studies suggest that patients without heart failure may not need post-MI β-blockers. The lack of data from randomized controlled clinical trials has led to clinical uncertainty and conflicting recommendations. Therefore, there are multiple information to revaluate the value of β-blocker therapy after a heart attack in absence of heart failure or left ventricular dysfunction and the time for new trials of an old group of drugs has arrived.

Downloads month by month

Downloads

Download data is not yet available.

Article Details